Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Hesperos Inc. logo — The Human-on-a-Chip Company

Hesperos Inc.

The Human-on-a-Chip Company

Founded 2015 United States Orlando, United States 64 employees Grant Total: $5.90M Biotechnology

General Information

Company Name Hesperos Inc.
Founded Year 2015
Location United States Orlando, United States
Employees 64
Industries Biotechnology
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Hesperos Inc.. To contact Hesperos Inc., visit hesperosinc.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Hesperos Inc. compare?

A PDF of Hesperos Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Hesperos Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Hesperos Inc.

Hesperos Inc. is a biotechnology startup based in the United States, founded in 2015, and has recently received a $1.90M grant investment from the National Institutes of Health on 25 August 2021. The company specializes in accelerating drug discovery by providing safety and efficacy testing of chemicals and novel therapeutics for the pharmaceutical, cosmetic, and food industries using its patented, Human-on-a-Chip platform. Hesperos' innovative technology brings together biologists, surface chemists, and engineers to produce some of the world's most advanced organs-on-a-chip platforms, recreating key components of organs in an interconnected, functional system. Their breakthrough technology enables unprecedented visibility into specific disease states and how the human body will respond to treatment, reducing the need for animal testing in drug discovery while enabling research into previously untreatable rare diseases. The company's functional, interconnected, human in vitro platform provides preclinical insight into the efficacy and toxicity of novel therapeutics, a process that previously required costly animal testing and human trials to determine. Hesperos' Human-on-a-Chip holds the potential to revolutionize the drug discovery process, offering a more ethical, cost-effective, and efficient path to bringing new drugs and treatments to market.

Business keywords: drug discovery, biomedical engineering, pharmaceutical research, safety testing, efficacy testing, organ-on-a-chip, human biology, preclinical research, in vitro testing

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $1.90M 1
National Institutes of Health
25 Aug 2021
Grant Undisclosed 1
National Institutes of Health
27 Sep 2019
Grant $4.00M 1
National Center for Advancing Translational Sciences(NCATS)
06 Sep 2018

Hesperos Inc. Alternatives & Competitors

View All Alternatives
Hesperos Inc. vs
Emulate, Inc.
Emulate, Inc. United States

Our Organ-on-a-Chip technology provides a high-fidelity window into the inner workings of human biol...

Series F
71 employees
Biotechnology, Health Care
Hesperos Inc. vs
AlveoliX
AlveoliX Switzerland

In-vitro models inspired by nature Ι Organs-on-Chip

Grant
11 employees
Biotechnology, Life Sciences
Hesperos Inc. vs
CN Bio
CN Bio United Kingdom

Generate human-specific efficacy and safety data with PhysioMimix® microphysiological systems.

Series B
59 employees
Biopharma, Biotechnology
Also compare with: Hesperos Inc. vs NeuCyte NeuCyte Hesperos Inc. vs Cellular Dynamics International Cellular Dynamics International Hesperos Inc. vs Qureator Qureator View all alternatives

FAQ About Hesperos Inc.

The Human-on-a-Chip Company
Hesperos Inc. was founded in 2015.
Hesperos Inc. is headquartered in Orlando, United States.
Hesperos Inc. operates in Biotechnology. Its work centres on drug discovery, biomedical engineering, pharmaceutical research and safety testing.
Hesperos Inc. has approximately 64 employees.
Hesperos Inc. has completed 3 funding rounds, raising a total of $5.90M. The latest funding stage is Grant.
Top alternatives and competitors to Hesperos Inc. include Emulate, Inc., AlveoliX , CN Bio, NeuCyte, Cellular Dynamics International. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Hesperos Inc. and Emulate, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Hesperos Inc., https://bouncewatch.com/company/hesperos-inc, updated 28 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes